1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Neurostimulation Devices Market Analysis By Product, By Application and Segment Forecasts to 2024

The neurostimulation devices market is expected to reach USD 9.8 billion by 2024, according to a new report by Grand View Research, Inc. The neurostimulation devices market is anticipated to witness a significant growth during the study period from 2016 to 2024. This growth is majorly attributed to high prevalence of chronic diseases, including migraine and epilepsy. Increasing adoption of unhealthy lifestyle, diet, and growth in aging population is resulting in a growing incidence of the chronic disease in individuals. However, adverse effects and risks associated with neurostimulation devices and presence of stringent device approval regulations are expected to hamper the growth.

Apart from the above mentioned factors, increasing incidence of road traffic accidents (RTAs) is also an additional factor propagating growth. Hence, the neurostimulation devices market holds enormous growth prospects and as a result manufacturers are participating in precise R&D exercises to develop new products empowered by advance technology. Some of the technological advancements such as the following are expected to serve as drivers:

Minimally invasive transdermal neuromodulation technology by Neurowave Medical Technologies

MRI safety incorporated devices by Medtronic Inc.

Further Key Findings from the Study Suggest:

North America is estimated to dominate the global neurostimulation devices market. The growing demand for neurostimulation devices as an add-on therapy, presence of high patient disposable incomes &patient awareness levels coupled with sophisticated healthcare infrastructure and high prevalence of target diseases, such as epilepsy, Parkinson’s disease, incontinence, etc., are expected to facilitate growth in near future

Asia Pacific is the fastest growing region in the neurostimulation devices. The high growth rate is explained by the following drivers:

Economic developments in emerging areas, such as India and China

Rising healthcare expenditures

Presence of unmet medical needs and untapped markets coupled with increasing patient disposable incomes

Changing lifestyle of the people resulting in various lifestyle-related diseases, for example, low-back pain resulting from long working hours.

Increasing RTAs, for example, nerve injuries (paralysis) due to RTA, which require neurostimulation postoperatively

The immense growth opportunities available in the Asia Pacific region have attracted manufacturers to enter these areas, for example, Medtronic aims at generating 20% of its revenue from emerging economies in the next 5 years, commencing from 2011

Spinal cord stimulation devices dominated the market in 2015 with highest share of over 54.0%. These devices were the prime neurostimulation devices to be commercialized, thus, hold a competitive edge over the rest of the devices in terms of share. The cost-effectiveness provided by these devices in terms of quality-adjusted life years will also drive the growth

Pain management dominated the overall market in terms of revenue share at over 65.0% in 2015. High global prevalence of chronic pain disorders and the growing adoption rates of neurostimulation devices for pain management were the major drivers recognized as contributors to the growth

The industry involves several global as well as local players. Some of the key players are Medtronic; St. Jude Medical; Boston Scientific Corporation; Cyberonics, Inc.; and Nevro Corporation. New and innovative product development using latest technology is expected to be a universal strategy followed by the players

For instance, in June, 2015, according to new data presented by Boston Scientific Corporation, the company’s spinal cord stimulator system, also known as Precision Spectra, claimed that the system provided better pain relief than its previous generation of Precision Plus SCS systems

Table Of Contents

Neurostimulation Devices Market Analysis By Product, By Application and Segment Forecasts to 2024
Table of Content

Chapter 1 Research Methodology
Chapter 2 Executive Summary
Chapter 3 Market Variables, Trends and Scope
3.1 Market Segmentation and Scope
3.1.1 Market Driver Analysis
3.1.1.1 Growing geriatric population base
3.1.1.2 Introduction of technological advancements
3.1.1.3 Growing demand for neurostimulation devices as an add on therapy
3.1.1.4 Increasing global prevalence of chronic diseases such as migraine and epilepsy and the presence of high unmet medical needs in these disease segments
3.1.1.5 Growing prevalence of lifestyle induced disorders such as obesity and depression
3.1.1.6 External funding for executing research and development exercises
3.1.1.7 Growing demand for minimally invasive surgeries
3.1.2 Market restraints
3.1.2.1 Adverse effects and risks associated with neurostimulation devices
3.1.2.2 Presence of stringent device approval regulations
3.1.2.3 Availability of external substitutes or alternative therapeutic procedures
3.2 Neurostimulation Devices - Market Dynamics
3.3 Key Opportunities Prioritized
3.4 Industry Analysis - Porter's
3.5 Neurostimulation Devices - PESTLE Analysis
3.6 Neurostimulation Devices Market: Company Market Share Analysis, 2015
Chapter 4 Market Categorization 1: Product Estimates and Trend Analysis
4.1 Neurostimulation Devices Market: Product Movement Analysis
4.2 Spinal Cord Stimulators Market
4.2.1 Spinal cord stimulators market, 2013 - 2024 (USD Million)
4.2.2 Spinal cord stimulators market, 2013 - 2024 (‘000 Units)
4.3 Deep Brain Stimulators Market
4.3.1 Deep brain stimulators market, 2013 - 2024 (USD Million)
4.3.2 Deep brain stimulators market, 2013 - 2024 (‘000 Units)
4.4 Sacral Nerve Stimulators Market
4.4.1 Sacral nerve stimulators market, 2013 - 2024 (USD Million)
4.4.2 Sacral nerve stimulators market, 2013 - 2024 (‘000 Units)
4.5 Vagus Nerve Stimulators Market
4.5.1 Vagus nerve stimulators market, 2013 - 2024 (USD Million)
4.5.2 Vagus nerve stimulators market, 2013 - 2024 (‘000 Units)
4.6 Gastric Electric Stimulators Market
4.6.1 Gastric electric stimulators market, 2013 - 2024 (USD Million)
4.6.2 Gastric electric stimulators market, 2013 - 2024 (‘000 Units)
Chapter 5 Market Categorization 2: Application Estimates and Trend Analysis
5.1 Neurostimulation Devices Market: Application Movement Analysis
5.2 Neurostimulation Devices for Pain Management Market
5.2.1 Neurostimulation devices for pain management market, 2013 - 2024 (USD Million)
5.3 Neurostimulation Devices for Epilepsy Market
5.3.1 Neurostimulation devices for epilepsy market, 2013 - 2024 (USD Million)
5.4 Neurostimulation Devices for Essential Tremor Market
5.4.1 Neurostimulation devices for essential tremor market, 2013 - 2024 (USD Million)
5.5 Neurostimulation Devices for Urinary and Fecal Incontinence Market
5.5.1 Neurostimulation devices for urinary and fecal incontinence market, 2013 - 2024 (USD Million)
5.6 Neurostimulation Devices for Depression Market
5.6.1 Neurostimulation devices for depression market, 2013 - 2024 (USD Million)
5.7 Neurostimulation Devices for Dystonia Market
5.7.1 Neurostimulation devices for dystonia market, 2013 - 2024 (USD Million)
5.8 Neurostimulation Devices for Gastroparesis Market
5.8.1 Neurostimulation devices for gastroparesis market, 2013 - 2024 (USD Million)
5.9 Neurostimulation Devices for Parkinson's Disease Market
5.9.1 Neurostimulation devices for Parkinson's disease market, 2013 - 2024 (USD Million)
5.10 Neurostimulation Devices for Other Diseases Market
5.10.1 Neurostimulation devices for other diseases market, 2013 - 2024 (USD Million)
Chapter 6 Market Categorization 3: Regional Estimates and Trend Analysis, by Product and Application
6.1 Neurostimulation Devices Market Share by Region, 2016 and 2024
6.1.1 North America
6.1.2 North America neurostimulation devices market, by country, 2013 - 2024 (USD Million)
6.1.3 North America neurostimulation devices market, by country, 2013 - 2024 (‘000 Units)
6.1.4 North America neurostimulation devices market, by product, 2013 - 2024 (USD Million)
6.1.5 North America neurostimulation devices market, by product, 2013 - 2024 (‘000 Units)
6.1.6 North America neurostimulation devices market, by application, 2013 - 2024 (USD Million)
6.1.6.1 US
6.1.6.2 US neurostimulation devices market, by product, 2013 - 2024 (USD Million)
6.1.6.3 US neurostimulation devices market, by product, 2013 - 2024 (‘000 Units)
6.1.6.4 US neurostimulation devices market, by application, 2013 - 2024 (USD Million)
6.1.6.5 Canada
6.1.6.6 Canada neurostimulation devices market, by product, 2013 - 2024 (USD Million)
6.1.6.7 Canada neurostimulation devices market, by product, 2013 - 2024 (‘000 Units)
6.1.6.8 Canada neurostimulation devices market, by application, 2013 - 2024 (USD Million)
6.1.7 Europe
6.1.8 Europe neurostimulation devices market, by country, 2013 - 2024 (USD Million)
6.1.9 Europe neurostimulation devices market, by country, 2013 - 2024 (‘000 Units)
6.1.10 Europe neurostimulation devices market, by product, 2013 - 2024 (USD Million)
6.1.11 Europe neurostimulation devices market, by product, 2013 - 2024 (‘000 Units)
6.1.12 Europe neurostimulation devices market, by application, 2013 - 2024 (USD Million)
6.1.12.1 Germany
6.1.12.2 Germany neurostimulation devices market, by product, 2013 - 2024 (USD Million)
6.1.12.3 Germany neurostimulation devices market, by product, 2013 - 2024 (‘000 Units)
6.1.12.4 Germany neurostimulation devices market, by application, 2013 - 2024 (USD Million)
6.1.12.5 U.K.
6.1.12.6 UK neurostimulation devices market, by product, 2013 - 2024 (USD Million)
6.1.12.7 UK neurostimulation devices market, by product, 2013 - 2024 (‘000 Units)
6.1.12.8 UK neurostimulation devices market, by application, 2013 - 2024 (USD Million)
6.2 Asia Pacific
6.2.1 Asia Pacific neurostimulation devices market, by country, 2013 - 2024 (USD Million)
6.2.2 Asia Pacific neurostimulation devices market, by country, 2013 - 2024 (‘000 Units)
6.2.3 Asia Pacific neurostimulation devices market, by product, 2013 - 2024 (USD Million)
6.2.4 Asia Pacific neurostimulation devices market, by product, 2013 - 2024 (‘000 Units)
6.2.5 Asia Pacific neurostimulation devices market, by application, 2013 - 2024 (USD Million)
6.2.5.1 China
6.2.5.2 China neurostimulation devices market, by product, 2013 - 2024 (USD Million)
6.2.5.3 China neurostimulation devices market, by product, 2013 - 2024 (‘000 Units)
6.2.5.4 China neurostimulation devices market, by application, 2013 - 2024 (USD Million)
6.2.5.5 Japan
6.2.5.6 Japan neurostimulation devices market, by product, 2013 - 2024 (USD Million)
6.2.5.7 Japan neurostimulation devices market, by product, 2013 - 2024 (‘000 Units)
6.2.5.8 Japan neurostimulation devices market, by application, 2013 - 2024 (USD Million)
6.3 Latin America
6.3.1 Latin America neurostimulation devices market, by country, 2013 - 2024 (USD Million)
6.3.2 Latin America neurostimulation devices market, by country, 2013 - 2024 (‘000 Units)
6.3.3 Latin America neurostimulation devices market, by product, 2013 - 2024 (USD Million)
6.3.4 Latin America neurostimulation devices market, by product, 2013 - 2024 (‘000 Units)
6.3.5 Latin America neurostimulation devices market, by application, 2013 - 2024 (USD Million)
6.3.5.1 Brazil
6.3.5.2 Brazil neurostimulation devices market, by product, 2013 - 2024 (USD Million)
6.3.5.3 Brazil neurostimulation devices market, by product, 2013 - 2024 (‘000 Units)
6.3.5.4 Brazil neurostimulation devices market, by application, 2013 - 2024 (USD Million)
6.3.5.5 Mexico
6.3.5.6 Mexico neurostimulation devices market, by product, 2013 - 2024 (USD Million)
6.3.5.7 Mexico neurostimulation devices market, by product, 2013 - 2024 (‘000 Units)
6.3.5.8 Mexico neurostimulation devices market, by application, 2013 - 2024 (USD Million)
6.3.5.9 Argentina
6.3.5.10 Argentina neurostimulation devices market, by product, 2013 - 2024 (USD Million)
6.3.5.11 Argentina neurostimulation devices market, by product, 2013 - 2024 (‘000 Units)
6.3.5.12 Argentina neurostimulation devices market, by application, 2013 - 2024 (USD Million)
6.3.6 MEA
6.3.7 MEA neurostimulation devices market, by country, 2013 - 2024 (USD Million)
6.3.8 MEA neurostimulation devices market, by country, 2013 - 2024 (‘000 Units)
6.3.9 MEA neurostimulation devices market, by product, 2013 - 2024 (USD Million)
6.3.10 MEA neurostimulation devices market, by product, 2013 - 2024 (‘000 Units)
6.3.11 MEA neurostimulation devices market, by application, 2013 - 2024 (USD Million)
6.3.11.1 South Africa
6.3.11.2 South Africa neurostimulation devices market, by product, 2013 - 2024 (USD Million)
6.3.11.3 South Africa neurostimulation devices market, by product, 2013 - 2024 (‘000 Units)
6.3.11.4 South Africa neurostimulation devices market, by Application, 2013 - 2024 (USD Million)
6.3.11.5 Saudi Arabia
6.3.11.6 Saudi Arabia neurostimulation devices market, by product, 2013 - 2024 (USD Million)
6.3.11.7 Saudi Arabia neurostimulation devices market, by product, 2013 - 2024 (‘000 Units)
6.3.11.8 Saudi Arabia neurostimulation devices market, by application, 2013 - 2024 (USD Million)
Chapter 7 Competitive Landscape
7.1 Company Profiles
7.2.1 Company overview
7.2.2 Financial performance
7.2.3 Product benchmarking
7.2.4 Strategic initiatives
7.2 Medtronic
7.2.1 Company overview
7.2.2 Financial performance
7.2.3 Product benchmarking
7.2.4 Strategic initiatives
7.3 St. Jude Medical
7.3.1 Company overview
7.3.2 Financial performance
7.3.3 Product benchmarking
7.3.4 Strategic initiatives
7.4 Boston Scientific Corporation
7.4.1 Company overview
7.4.2 Financial performance
7.4.3 Product benchmarking
7.4.4 Strategic initiatives
7.5 Cyberonics
7.5.1 Company overview
7.5.2 Financial performance
7.5.3 Product benchmarking
7.5.4 Strategic initiatives
7.6 Nevro Corporation
7.6.1 Company overview
7.6.2 Financial performance
7.6.3 Product benchmarking
7.6.4 Strategic initiatives
7.7 Neuronetics, Inc.
7.7.1 Company overview
7.7.2 Financial performance
7.7.3 Product benchmarking
7.7.4 Strategic initiatives
7.8 Uroplasty, Inc.
7.8.1 Company overview
7.8.2 Financial performance
7.8.3 Product benchmarking
7.8.4 Strategic initiatives
7.9 Codman and Shurtleff, Inc.
7.9.1 Company overview
7.9.2 Financial performance
7.9.3 Product benchmarking
7.9.4 Strategic initiatives
7.10 IntraPace, Inc.
7.10.1 Company overview
7.10.2 Financial performance
7.10.3 Product benchmarking
7.10.4 Strategic initiatives
List of Table


TABLE 1 Key spinal cord stimulators and their product approval status
TABLE 2 Key deep brain stimulators and their product approval status
TABLE 3 Key sacral nerve stimulators and their product approval status
TABLE 4 Key vagus nerve stimulators and their product approval status
TABLE 5 Global neurostimulation devices market, by geography, 2013 - 2024 (USD Million)
TABLE 6 Global neurostimulation devices market, by geography, 2013 - 2024 (‘000 Units)
TABLE 7 North America neurostimulation devices market, by country, 2013 - 2024 (USD Million)
TABLE 8 North America neurostimulation devices market, by country, 2013 - 2024 (‘000 Units)
TABLE 9 North America neurostimulation devices market, by product, 2013 - 2024 (USD Million)
TABLE 10 North America neurostimulation devices market, by product, 2013 - 2024 (‘000 Units)
TABLE 11 North America neurostimulation devices market, by application, 2013 - 2024 (USD Million)
TABLE 12 US Neurostimulation devices market, by product, 2013 - 2024 (USD Million)
TABLE 13 US Neurostimulation devices market, by product, 2013 - 2024 (‘000 Units)
TABLE 14 US neurostimulation devices market, by application, 2013 - 2024 (USD Million)
TABLE 15 Canada neurostimulation devices market, by product, 2013 - 2024 (USD Million)
TABLE 16 Canada neurostimulation devices market, by product, 2013 - 2024 (‘000 Units)
TABLE 17 Canada neurostimulation devices market, by application, 2013 - 2024 (USD Million)
TABLE 18 Europe neurostimulation devices market, by country, 2013 - 2024 (‘000 Units)
TABLE 19 Europe neurostimulation devices market, by product, 2013 - 2024 (USD Million)
TABLE 20 Europe neurostimulation devices market, by product, 2013 - 2024 (‘000 Units)
TABLE 21 Europe neurostimulation devices market, by application, 2013 - 2024 (USD Million)
TABLE 22 Germany neurostimulation devices market, by product, 2013 - 2024 (USD Million)
TABLE 23 Germany neurostimulation devices market, by product, 2013 - 2024 (‘000 Units)
TABLE 24 Germany neurostimulation devices market, by application, 2013 - 2024 (USD Million)
TABLE 25 UK neurostimulation devices market, by product, 2013 - 2024 (USD Million)
TABLE 26 UK neurostimulation devices market, by product, 2013 - 2024 (‘000 Units)
TABLE 27 UK neurostimulation devices market, by application, 2013 - 2024 (USD Million)
TABLE 28 Asia Pacific neurostimulation devices market, by country, 2013 - 2024 (USD Million)
TABLE 29 Asia Pacific neurostimulation devices market, by country, 2013 - 2024 (‘000 Units)
TABLE 30 Asia Pacific neurostimulation devices market, by product, 2013 - 2024 (USD Million)
TABLE 31 Asia Pacific neurostimulation devices market, by product, 2013 - 2024 (‘000 Units)
TABLE 32 Asia Pacific devices market, by application, 2013 - 2024 (USD Million)
TABLE 33 China neurostimulation devices market, by product, 2013 - 2024 (USD Million)
TABLE 34 China neurostimulation devices market, by product, 2013 - 2024 (‘000 Units)
TABLE 35 China neurostimulation devices market, by application, 2013 - 2024 (USD Million)
TABLE 36 Japan neurostimulation devices market, by product, 2013 - 2024 (USD Million)
TABLE 37 Japan neurostimulation devices market, by product, 2013 - 2024 (‘000 Units)
TABLE 38 Japan neurostimulation devices market, by application, 2013 - 2024 (USD Million)
TABLE 39 Latin America neurostimulation devices market, by country, 2013 - 2024 (USD Million)
TABLE 40 Latin America neurostimulation devices market, by country, 2013 - 2024 (‘000 Units)
TABLE 41 Latin America neurostimulation devices market, by product, 2013 - 2024 (USD Million)
TABLE 42 Latin America neurostimulation devices market, by product, 2013 - 2024 (‘000 Units)
TABLE 43 Latin America neurostimulation devices market, by application, 2013 - 2024 (USD Million)
TABLE 44 Brazil neurostimulation devices market, by product, 2013 - 2024 (USD Million)
TABLE 45 Brazil neurostimulation devices market, by product, 2013 - 2024 (‘000 Units)
TABLE 46 Brazil neurostimulation devices market, by application, 2013 - 2024 (USD Million)
TABLE 47 Mexico neurostimulation devices market, by product, 2013 - 2024 (USD Million)
TABLE 48 Mexico neurostimulation devices market, by product, 2013 - 2024 (‘000 Units)
TABLE 49 Mexico neurostimulation devices market, by application, 2013 - 2024 (USD Million)
TABLE 50 Argentina neurostimulation devices market, by product, 2013 - 2024 (USD Million)
TABLE 51 Argentina neurostimulation devices market, by product, 2013 - 2024 (‘000 Units)
TABLE 52 Argentina neurostimulation devices market, by application, 2013 - 2024 (USD Million)
TABLE 53 MEA neurostimulation devices market, by country, 2013 - 2024 (USD Million)
TABLE 54 MEA neurostimulation devices market, by country, 2013 - 2024 (‘000 Units)
TABLE 55 MEA neurostimulation devices market, by product, 2013 - 2024 (USD Million)
TABLE 56 MEA neurostimulation devices market, by product, 2013 - 2024 (‘000 Units)
TABLE 57 MEA devices market, by application, 2013 - 2024 (USD Million)
TABLE 58 South Africa neurostimulation devices market, by product, 2013 - 2024 (USD Million)
TABLE 59 South Africa neurostimulation devices market, by product, 2013 - 2024 (‘000 Units)
TABLE 60 South Africa neurostimulation devices market, by application, 2013 - 2024 (USD Million)
TABLE 61 Saudi Arabia neurostimulation devices market, by product, 2013 - 2024 (USD Million)
TABLE 62 Saudi Arabia neurostimulation devices market, by product, 2013 - 2024 (‘000 Units)
TABLE 63 Saudi Arabia neurostimulation devices market, by application, 2013 - 2024 (USD Million)


List of Figures


FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value-chain-based sizing and forecasting
FIG. 6 QFD modeling for market share assessment
FIG. 7 Market trends and outlook
FIG. 8 Market segmentation and scope
FIG. 9 Market driver relevance analysis (Current and future impact)
FIG. 10 Global percentage of population, by age group, 2000 and 2050
FIG. 11 Neurostimulation devices market dynamics
FIG. 12 Key opportunities prioritized
FIG. 13 Neurostimulation devices market - Porter's analysis
FIG. 14 Neurostimulation devices market - PESTEL analysis
FIG. 15 Neurostimulation devices market: Company Market Share Analysis, 2015
FIG. 16 Neurostimulation devices market: Product movement analysis
FIG. 17 Spinal cord stimulators market, 2013 - 2024 (USD Million)
FIG. 18 Spinal cord stimulators market, 2013 - 2024 (‘000 Units)
FIG. 19 Deep brain stimulators market, 2013 - 2024 (USD Million)
FIG. 20 Deep brain stimulators market, 2013 - 2024 (‘000 Units)
FIG. 21 Sacral nerve stimulators market, 2013 - 2024 (USD Million)
FIG. 22 Sacral nerve stimulators market, 2013 - 2024 (‘000 Units)
FIG. 23 Vagus nerve stimulators market, 2013 - 2024 (USD Million)
FIG. 24 Vagus nerve stimulators market, 2013 - 2024 (‘000 Units)
FIG. 25 Gastric electric stimulators market, 2013 - 2024 (USD Million)
FIG. 26 Gastric electric stimulators market, 2013 - 2024 (‘000 Units)
FIG. 27 Neurostimulation devices market: Product movement analysis
FIG. 28 Neurostimulation devices for pain management market, 2013 - 2024 (USD Million)
FIG. 29 Neurostimulation devices for epilepsy market, 2013 - 2024 (USD Million)
FIG. 30 Neurostimulation devices for essential tremor market, 2013 - 2024 (USD Million)
FIG. 31 Neurostimulation devices for urinary and fecal incontinence market, 2013 - 2024 (USD Million)
FIG. 32 Neurostimulation devices for depression market, 2013 - 2024 (USD Million)
FIG. 33 Neurostimulation devices for dystonia market, 2013 - 2024 (USD Million)
FIG. 34 Neurostimulation devices for gastroparesis market, 2013 - 2024 (USD Million)
FIG. 35 Neurostimulation devices for Parkinson's disease market, 2013 - 2024 (USD Million)
FIG. 36 Neurostimulation devices for other diseases market, 2013 - 2024 (USD Million)
FIG. 37 Neurostimulation devices revenue share by geography, 2016 and 2024
FIG. 38 Europe neurostimulation devices market, by country, 2013 - 2024 (USD Million)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.